Table 4.
Blood pressure profiles (mean ± SD).
| OPP treatment (n=25) | Control treatment (n=25) | |
|---|---|---|
| Systolic (mm Hg) | ||
| Day 1 | 117.60 ± 13.32 | 115.20 ± 10.46 |
| Day 30 | 112.24 ± 11.35 | 112.64 ± 12.08 |
| Day 60 | 114.64 ± 10.32 | 112.64 ± 13.26 |
| Diastolic (mm Hg) | ||
| Day 1* | 79.92 ± 7.91 | 76.40 ± 7.44 |
| Day 30 | 74.48 ±7.33 | 74.24 ± 7.38 |
| Day 60 | 74.32 ± 7.02 | 76.88 ± 8.81 |
| Pulse rate (bpm) | ||
| Day 1 | 68.72 ± 3.26 | 69.12 ± 3.96 |
| Day 30 | 70.56 ± 3.81 | 71.04 ± 4.62 |
| Day 60 | 68.80 ± 4.04 | 69.04 ± 3.61 |
*Baseline diastolic level (day 1) was significantly different between treatments, p = 0.043 (Wilcoxon’s signed-rank test). Values were further used as covariate in repeated measures. The time × treatment analysis was however not significant, p = 0.118 (2-factor repeated measures ANOVA).